Method for inhibiting RNA translation using chimeric oligonucleoside compounds
US6262036A · kind A · utility
24Cited by
3References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 24, 2000 |
| Grant date | Jul 17, 2001 |
| Priority date | — |
| Expiry date | Jan 24, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chimeric oligonucleoside compounds, and methods of preparing and formulating the same, are disclosed. The compounds and compositions are useful in activating RNaseH-mediated cleavage of target ribonucleic acid sequences, and in treating disease conditions relating to such sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.